Aleva Neurotherapeutics: CE-Mark for Aleva's Deep Brain Stimulation

After receiving approval from the US Food and Drug Administration, Aleva Neurotherapeutics has obtained the CE approval of its MRI labeling for the directSTIM DBS System in Neuromodulation - supporting a new category of patients who are likely to undergo an MRI exam after DBS surgery. The commercial journey has started as the company partners with neurological clinics across Europe.